Saturday, October 3, 2026

EUR/CHF Slides By 1% In The Last 10 Sessions

ViaNews Editorial Team

September 8, 2024

EUR/CHF Slides By 1% In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.05% for the last 10 sessions. At 17:06 EST on Sunday, 8 September, EUR/CHF (EURCHF) is $0.94.

EUR/CHF's yearly highs and lows, it's 3.566% up from its 52-week low and 5.821% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was 0.07%, 0.02%, and 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.14% (last week), 0.32% (last month), and 0.29% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Friday, 6 September, "In terms of support, the USD/JPY pair is falling toward the seven-month low of 141.69, recorded on August 5. ", "On the upside, the USD/JPY pair might first encounter a barrier at the nine-day EMA around 144.60, followed by the 21-day EMA at 146.02. "
  • Usd/jpy finds support near 142.00, recovers few pips from over one-month low ahead of NFP. According to FXStreet on Friday, 6 September, "The USD/JPY pair remains under some selling pressure for the fourth straight day and drops to over a one-month low, around the 142.00 round-figure mark on Friday. ", "Any meaningful recovery for the USD/JPY pair, however, seems elusive in the wake of divergent Fed-Bank of Japan (BoJ) policy outlook. "
  • Usd/jpy: A death cross is upon us – OCBC. According to FXStreet on Friday, 6 September, "Fed-BoJ policy shifts and growing pace of normalisation can bring about faster narrowing of UST-JGB yield differentials and this should continue to underpin the broader direction of travel for USD/JPY to the downside."
  • Usd/jpy holds losses after weak nfps from the US. According to FXStreet on Friday, 6 September, "The USD/JPY tallies 0.30% losses on Friday as the USD extends its broad weakness after soft Nonfarm Payrolls figures from the US.", "The USD/JPY outlook is negative as the Relative Strength Index (RSI) hovers near the oversold level of 30, signaling potential downward momentum which could eventually lead to a correction though. "
  • Usd/jpy price forecast: downtrend resumes boosted by falling US yields. According to FXStreet on Friday, 6 September, "The USD/JPY extended its losses late on Friday's North American session, bolstered by the losses of the yield of the US 10-year T-note. ", "The USD/JPY downtrend continued after the latest US Nonfarm Payrolls report sparked volatility in the pair, which seesawed within a 230-pip range on the day, but as the dust settled, sellers remained in charge."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com